Atlas Trials

Study of ISIS 703802 in Participants With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease

Clinical trial NCT03371355 · COMPLETED

Trial details

NCT number
NCT03371355
Sponsor
Akcea Therapeutics
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
NAFLDDiabetes Mellitus, Type 2HypertriglyceridemiaFatty Liver, Nonalcoholic
Start date
2017-12-21
Primary completion
2019-11-21
Enrollment
105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.